Iovance Biotherapeutics, Inc. IOVA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$353.86M+9.5% | -$390.98M+1.7% | -$397.63M-2.0% | -$389.92M-3.9% | -$375.36M-0.9% | ||
| $12.93M+2.0% | $12.68M+3.7% | $12.23M-0.1% | $12.25M+3.4% | $11.85M-3.3% | ||
| $49.93M-18.9% | $61.58M-23.7% | $80.74M-19.1% | $99.84M-13.5% | $115.36M+5.2% | ||
| -$270.79M+10.5% | -$302.41M+6.4% | -$323.14M-6.5% | -$303.41M+9.3% | -$334.39M+5.3% | ||
| $34.23M+1.2% | $33.84M+18.0% | $28.68M+42.5% | $20.13M+53.5% | $13.11M+18.4% | ||
| $43.02M-9.4% | $47.5M— | —— | —— | —— | ||
| $251.79M-16.3% | $300.77M+21.8% | $246.91M+23.0% | $200.81M-41.0% | $340.4M-12.9% | ||
| —— | —— | —— | —— | $37.43M+163% | ||
| -$305.02M+9.3% | -$336.24M+4.4% | -$351.82M-8.7% | -$323.54M+6.9% | -$347.5M+4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Iovance Biotherapeutics, Inc. generate?
- Iovance Biotherapeutics, Inc. (IOVA) generated -$270.8M in operating cash flow over the trailing twelve months.
- What is Iovance Biotherapeutics, Inc.'s free cash flow?
- After $34.2M of capital expenditures, Iovance Biotherapeutics, Inc.'s free cash flow was -$305.0M over the trailing twelve months, up 12.2% year over year.
- Where does Iovance Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Iovance Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
